Bmal1-flox Mouse
一般名
Bmal1-flox
製品ID
S-CKO-18722
背景情報
C57BL/6NCya
系統ID
CKOCMP-11865-Bmal1-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Bmal1-flox Mouse(カタログ番号S-CKO-18722)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Bmal1-flox
系統ID
CKOCMP-11865-Bmal1-B6N-VA
遺伝子名
製品ID
S-CKO-18722
遺伝子別名
MOP3, Arnt3, Arntl, BMAL1b, bHLHe5, bmal1b'
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conditional knockout
染色体
Chr 7
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000047321
NCBIトランスクリプトID
NM_007489
ターゲット領域
Exon 6~8
有効領域の大きさ
~2.4 kb
遺伝子研究の概要
Bmal1, also known as Brain and muscle arnt-like protein 1, is a crucial transcription factor in the circadian clock. It forms a heterodimer with Clock, binding to the E-box element in the promoters of genes like Per and Cry, regulating the rhythmic expression of circadian-controlled genes. It is associated with multiple biological processes, including immune regulation, metabolism, and reproduction, and thus is of great biological importance. Genetic models, such as knockout (KO) and conditional knockout (CKO) mouse models, are valuable for studying its functions [5].
In the context of disease, Bmal1 down-regulation in cardiomyocyte-specific knockout (CKB) and type 2 diabetes (T2D) mice heart accelerates cardiac hypertrophy and diastolic dysfunction in diabetic cardiomyopathy, while over-expression ameliorates these pathological changes. This occurs through Bcl2/IP3R-mediated mitochondrial Ca2 + overload [1]. Disruption of BMAL1 in mice elicits an endocrine adaption impacting insulin sensitivity and liver disease, showing a different association with fibrosis development compared to humans [2]. In sepsis-induced acute lung injury, BMAL1 deficiency in macrophages exacerbates systemic inflammation and lung injury by up-regulating CXCL2 and intensifying neutrophil-related lung injury [3]. In sepsis-induced acute kidney injury, BMAL1 over-expression alleviates renal tubular injury by reducing ferroptosis levels through inhibiting YAP expression and the Hippo pathway [4]. Bmal1 -/- mutant mice with a non-functional circadian clock show more severe and constant colitis, with disrupted daily rhythms in inflammation and epithelial proliferation [6]. In acute myeloid leukemia, knocking down BMAL1 inhibits cell growth, promotes ferroptosis, and enhances the efficacy of certain cancer drugs [7]. In glioblastoma, silencing BMAL1 promotes M1/M2 polarization through the LDHA/lactate axis, sensitizing cells to bevacizumab [8]. Also, BMAL1-KO mice are infertile, with impaired reproductive organs, gametes, and disrupted hypothalamus-pituitary-gonadal (H-P-G) axis function [9].
In conclusion, Bmal1 plays essential roles in maintaining normal physiological functions, including circadian rhythm regulation, immune homeostasis, metabolism, and reproduction. Studies using Bmal1 KO/CKO mouse models have revealed its significant contributions to various disease areas such as diabetes-related cardiomyopathy, liver diseases, sepsis-related organ injuries, colitis, leukemia, glioblastoma, and reproductive disorders. Understanding Bmal1 function provides insights into disease mechanisms and potential therapeutic targets.
References:
1. Zhang, Nannan, Yu, Hao, Liu, Tianzi, Hou, Xiaofeng, Zou, Jiangang. 2023. Bmal1 downregulation leads to diabetic cardiomyopathy by promoting Bcl2/IP3R-mediated mitochondrial Ca2+ overload. In Redox biology, 64, 102788. doi:10.1016/j.redox.2023.102788. https://pubmed.ncbi.nlm.nih.gov/37356134/
2. Jouffe, Céline, Weger, Benjamin D, Martin, Eva, Uhlenhaut, N Henriette, Gachon, Frédéric. 2022. Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease. In Proceedings of the National Academy of Sciences of the United States of America, 119, e2200083119. doi:10.1073/pnas.2200083119. https://pubmed.ncbi.nlm.nih.gov/35238641/
3. Zeng, Ting, Liang, Long, Deng, Wenjun, Liu, Jing, Yang, Minghua. 2024. BMAL1 plays a crucial role in immune homeostasis during sepsis-induced acute lung injury. In Biochemical pharmacology, 226, 116379. doi:10.1016/j.bcp.2024.116379. https://pubmed.ncbi.nlm.nih.gov/38908531/
4. Yang, Songyuan, Ye, Zehua, Chen, Wu, Li, Wei, Cheng, Fan. 2024. BMAL1 alleviates sepsis-induced AKI by inhibiting ferroptosis. In International immunopharmacology, 142, 113159. doi:10.1016/j.intimp.2024.113159. https://pubmed.ncbi.nlm.nih.gov/39303541/
5. Fan, Xu-Li, Song, Ying, Qin, Dong-Xu, Lin, Pei-Yao. 2021. Regulatory Effects of Clock and Bmal1 on Circadian Rhythmic TLR Expression. In International reviews of immunology, 42, 101-112. doi:10.1080/08830185.2021.1931170. https://pubmed.ncbi.nlm.nih.gov/34544330/
6. Taleb, Zainab, Carmona-Alcocer, Vania, Stokes, Kyle, Khan, Waliul I, Karpowicz, Phillip. 2022. BMAL1 Regulates the Daily Timing of Colitis. In Frontiers in cellular and infection microbiology, 12, 773413. doi:10.3389/fcimb.2022.773413. https://pubmed.ncbi.nlm.nih.gov/35223537/
7. Zheng, Hong, Wu, Ting, Lin, Zhi, Li, Jia-Da, Yang, Minghua. 2024. Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway. In Journal of cancer research and clinical oncology, 150, 231. doi:10.1007/s00432-024-05753-y. https://pubmed.ncbi.nlm.nih.gov/38703241/
8. Wang, Fan, Liao, Wenjun, Li, Caiyan, Zhu, Ling. 2024. Silencing BMAL1 promotes M1/M2 polarization through the LDHA/lactate axis to promote GBM sensitivity to bevacizumab. In International immunopharmacology, 134, 112187. doi:10.1016/j.intimp.2024.112187. https://pubmed.ncbi.nlm.nih.gov/38733825/
9. Jiang, Yin, Li, Shiping, Xu, Wenming, Li, Jinhui, Mu, Dezhi. 2022. Critical Roles of the Circadian Transcription Factor BMAL1 in Reproductive Endocrinology and Fertility. In Frontiers in endocrinology, 13, 818272. doi:10.3389/fendo.2022.818272. https://pubmed.ncbi.nlm.nih.gov/35311235/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
